Individuals who smoke and carry the NAT2 slow-acetylation mutation are at higher risk of developing bladder cancer than those without the mutation.

Name: Individuals who smoke and carry the NAT2 slow-acetylation mutation are at higher risk of developing bladder cancer than those without the mutation.
Brand: Quizplus
Rating: 4.8 (56 reviews)

Question

Quizplus · Accepted Answer

The NAT2 slow-acetylation mutation affects the body's ability to process certain carcinogens found in tobacco smoke, increasing the risk of bladder cancer in individuals who smoke.

Individuals Who Smoke and Carry the NAT2 Slow-Acetylation Mutation Are